Oncotelic Therapeutics, Inc. (OTLC) Deferred Tax Liabilities, Gross

Oncotelic Therapeutics, Inc. Deferred Tax Liabilities, Gross

Oncotelic Therapeutics, Inc. (OTLC) had Deferred Tax Liabilities, Gross of $111.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net

us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-08-13

• 2026-06-30: Deferred Tax Liabilities, Gross $111.55M.
• 2026-03-31: Deferred Tax Liabilities, Gross $111.55M.
• 2025-12-31: Deferred Tax Liabilities, Gross $111.55M.